Get started
H&R GMBH & CO. KGAA NPVHH

H&R GMBH & CO. KGAA NPV

4.97EURD
+0.05+1.02%
At close at 14:35 GMT
EUR
No trades
See on Supercharts
Overview
Financials
News Ideas Discussions Technicals Forecast Seasonals

0RRC fundamentals

Key facts

Market capitalization‪185.36 M‬EUR
Dividend yield (indicated)2.01%
Price to earnings Ratio (TTM)16.58
Basic EPS (TTM)0.30EUR
Founded2002
Employees (FY)‪1.71 K‬
CEONiels Heinz Hansen
Websitehur.com
About

H&R GmbH & Co. KGaA is a holding company, which engages in the manufacture of mineral oil specialties. It operates through the following segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment includes paraffins, white oils, plasticizers, base oils, lubricants, and other crude-oil-based specialty products. The ChemPharm Sales segment encompasses foreign firms that process chemical pharmaceutical raw materials and distribute it as new products. The Plastics segment engages in manufacturing of precision plastic components. The company was founded on December 16, 1919 and is headquartered in Salzbergen, Germany.

Ownership
‪‪37.22 M‬‬
Closely held shares
‪‪25.12 M‬‬ (67.48%)
Free Float shares
‪‪12.10 M‬‬ (32.52%)
Closely held shares
‪‪25.12 M‬‬ (67.48%)
Free Float shares
‪‪12.10 M‬‬ (32.52%)
Capital structure
Market cap
‪‪185.36 M‬‬
Debt
‪‪169.48 M‬‬
Minority interest
‪‪40.86 M‬‬
Cash & equivalents
‪‪59.13 M‬‬
Enterprise value
‪‪336.57 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪185.36 M‬‬
Price to earning ratio (P/E)
16.58x
Price to sales ratio (P/S)
0.14x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
16.58x
Price to sales ratio (P/S)
0.14x
Valuation ratios
‪0.00‬
‪0.04‬
‪0.07‬
‪0.11‬
‪0.14‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪7.00‬
‪14.00‬
‪21.00‬
‪28.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪0.35%‬
‪0.60%‬
‪0.85%‬
‪1.10%‬
‪1.35%‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪90.00 M‬‬
‪‪180.00 M‬‬
‪‪270.00 M‬‬
‪‪360.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪90.00 M‬‬
‪‪180.00 M‬‬
‪‪270.00 M‬‬
‪‪360.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪90.00 M‬‬
‪‪180.00 M‬‬
‪‪270.00 M‬‬
‪‪360.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
ChemPharm Refining
ChemPharm Sales
Plastics
By country
Period: 2024
Germany
Rest of World
Rest of Europe

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪90.00 M‬‬
‪‪180.00 M‬‬
‪‪270.00 M‬‬
‪‪360.00 M‬‬
Actual
Estimate
Earnings
Next:Mar 26, 2026
2021
2022
2023
2024
2025
‪0.00‬
‪0.40‬
‪0.80‬
‪1.20‬
‪1.60‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
33.69%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
2.01%
Last payment
0.10
Last ex-date
May 28, 2025
Last pay date
Today
Dividend history
‪0.0%‬
‪0.8%‬
‪1.6%‬
‪2.4%‬
‪3.2%‬
2020
2021
2022
2023
2024
‪0.00‬
‪0.03‬
‪0.05‬
‪0.08‬
‪0.10‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−70.00 M‬‬
‪0.00‬
‪‪70.00 M‬‬
‪‪140.00 M‬‬
‪‪210.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪150.00 M‬‬
‪‪300.00 M‬‬
‪‪450.00 M‬‬
‪‪600.00 M‬‬
Assets
Liabilities